middle.news
Epiminder Advances US Epilepsy Monitor with $42.7m FY26 Loss and $125m IPO
8:48am on Wednesday 26th of August, 2026 AEST
•
Healthcare
Read Story
Epiminder Advances US Epilepsy Monitor with $42.7m FY26 Loss and $125m IPO
8:48am on Wednesday 26th of August, 2026 AEST
Key Points
FY26 loss widens 34% to $42.7 million
$125 million IPO completed in December 2025
50 patients enrolled in US DETECT trial by July 2026
Next-generation Minder device design near completion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Epiminder (ASX:EPI)
OPEN ARTICLE